These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12444461)

  • 41. [Testing the effects of hydrazones and osazones of sugars on Trichomonas vaginalis (author's transl)].
    Demes P; Linek K; Nemogová E; Catár G; Klobusický M; Valent M
    Bratisl Lek Listy; 1982 Mar; 77(3):303-10. PubMed ID: 6978755
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of Pimaricin as a trichomonacidal drug in in vitro experiments].
    Michalowski R; Zatorska H
    Wiad Parazytol; 1973; 19(3):503-4. PubMed ID: 4542511
    [No Abstract]   [Full Text] [Related]  

  • 43. Larvicidal activity of Bacillus thuringiensis natural isolates; indigenous to Japan, against two nematoceran insect pests occurring in urban sewage environments.
    Saitoh H; Higuchi K; Mizuki E; Ohba M
    Microbiol Res; 1996 Aug; 151(3):263-71. PubMed ID: 8817917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Premature with trichomoniasis: report of one case.
    Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
    Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of the round forms of Trichomonas vaginalis].
    Ciucă T; Mihalache V
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(6):541-6. PubMed ID: 4539851
    [No Abstract]   [Full Text] [Related]  

  • 46. [The antitrichomonal activity of the sodium salts of anthranilic acid].
    Mokhort NA; Padchenko IK; Sol'skiĭ IaP
    Akush Ginekol (Mosk); 1990 Sep; (9):70-1. PubMed ID: 2278315
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of Bacillus thuringiensis ser. jordanica (serotype H71), a novel serovariety isolated in Jordan.
    Khyami-Horani H; Hajaij M; Charles JF
    Curr Microbiol; 2003 Jul; 47(1):26-31. PubMed ID: 12783189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycogen medium, antitrichomonal drug activity in vaginal liquids.
    Simonetti G; Simonetti N; D'Auria FD
    Drugs Exp Clin Res; 1989; 15(11-12):545-7. PubMed ID: 2637795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Susceptibility of archaea to the antibiotic effect of the parasporal inclusion proteins from Bacillus thuringiensis subspecies].
    Iudina TG; Briukhanov AL; Netrusov AI
    Mikrobiologiia; 2004; 73(1):25-30. PubMed ID: 15074036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacologic study of the amebicidal and trichomonicidal activity of ornidazole (1-(2-hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole].
    Savel J
    Ann Pharm Fr; 1976; 34(7-8):249-59. PubMed ID: 188370
    [No Abstract]   [Full Text] [Related]  

  • 51. Perinatal transmission of Trichomonas vaginalis: a case report.
    Schwandt A; Williams C; Beigi RH
    J Reprod Med; 2008 Jan; 53(1):59-61. PubMed ID: 18251366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why is Trichomonas vaginalis ignored?
    Bowden FJ; Garnett GP
    Sex Transm Infect; 1999 Dec; 75(6):372-4. PubMed ID: 10754936
    [No Abstract]   [Full Text] [Related]  

  • 53. Occurrence of parasporin-producing Bacillus thuringiensis in Vietnam.
    Yasutake K; Binh ND; Kagoshima K; Uemori A; Ohgushi A; Maeda M; Mizuki E; Yu YM; Ohba M
    Can J Microbiol; 2006 Apr; 52(4):365-72. PubMed ID: 16699587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel Bacillus thuringiensis strain LLB6, isolated from bryophytes, and its new cry2Ac-type gene.
    Zhang LL; Lin J; Luo L; Guan CY; Zhang QL; Guan Y; Zhang Y; Ji JT; Huang ZP; Guan X
    Lett Appl Microbiol; 2007 Mar; 44(3):301-7. PubMed ID: 17309508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parasporin-1, a novel cytotoxic protein to human cells from non-insecticidal parasporal inclusions of Bacillus thuringiensis.
    Katayama H; Yokota H; Akao T; Nakamura O; Ohba M; Mekada E; Mizuki E
    J Biochem; 2005 Jan; 137(1):17-25. PubMed ID: 15713879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment.
    Salas A; Hamill MM; Tuddenham S
    JAMA Intern Med; 2019 Feb; 179(2):247-248. PubMed ID: 30575848
    [No Abstract]   [Full Text] [Related]  

  • 57. Paromomycin for nitroimidazole-resistant trichomonosis.
    Nyirjesy P; Weitz MV; Gelone SP; Fekete T
    Lancet; 1995 Oct; 346(8982):1110. PubMed ID: 7564825
    [No Abstract]   [Full Text] [Related]  

  • 58. [The efficacy of established, systemically active trichomonacidal agents in the infection model tri-chomonas vaginalis/rat (author's transl)].
    Meingassner JG; Mieth H
    Arzneimittelforschung; 1977; 27(3):638-9. PubMed ID: 577434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies of compounds with potential antiparasitic action. VIII. New oxime ethers in the 1-thiochromone system].
    Kadłubowski R; Błaszkowska J; Horwatt E
    Wiad Parazytol; 1990; 36(5-6):269-74. PubMed ID: 2131701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lectin activity of Bacillus thuringiensis parasporal inclusion proteins.
    Akao T; Mizuki E; Yamashita S; Saitoh H; Ohba M
    FEMS Microbiol Lett; 1999 Oct; 179(2):415-21. PubMed ID: 10518745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.